CoChat
Sign Up
Cited by 32

Socio-Economic Inequity: Diabetes in New Zealand

Holder-Pearson, Lui, Chase, James Geoffrey·2022·Frontiers in Medicine
DOI 10.3389/fmed.2022.756223PMC PMC9127724
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2022.756223

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. [2]Jansen RM Sundborn G Cutfield R Yu D Simmons D. Ethnic inequity in diabetes outcomes-inaction in the face of need. N Z Med J. (2020) 133: 8– 10. Available online at: https://journal.nzma.org.nz/journal-articles/ethnic-inequity-in-diabetes-outcomes-inaction-in-the-face-of-need 33223543
  2. [4]Dalbo VJ Teramoto M Roberts MD Scanlan AT. Lack of reality: positive self-perceptions of health in the presence of disease. Sports. (2017) 5: 23. 10.3390/sports5020023 29910383 PMC5968989 · DOI
  3. [7]Norhammar A Mellbin L Cosentino F. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor. Eur J Prev Cardiol. (2017) 24: 52– 60. 10.1177/2047487317709554 28618910 · DOI
  4. [8]Wright AK Kontopantelis E Emsley R Buchan I Sattar N Rutter MK. Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups. Diabetes Care. (2017) 40: 338– 45. 10.2337/dc16-1616 27998911 · DOI
  5. [9]Zhou M Liu J Hao Y Liu J Huo Y Smith SC. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc Diabetol. (2018) 17: 1– 14. 10.1186/s12933-018-0793-x 30482187 PMC6258152 · DOI · Paper page
  6. [10]Walker J Colhoun H Livingstone S McCrimmon R Petrie J Sattar N. Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study. Diabetologia. (2018) 61: 108– 16. 10.1007/s00125-017-4478-x 29075822 PMC6448945 · DOI
  7. [11]Yu D Zhao Z Osuagwu UL Pickering K Baker J Cutfield R. Ethnic differences in mortality and hospital admission rates between Māori, Pacific, and European New Zealanders with type 2 diabetes between 1994 and 2018: a retrospective, population-based, longitudinal cohort study. The Lancet Global Health. (2021) 9: e209– 17. 10.1016/S2214-109X(20)30412-5 33069275 · DOI
  8. [12]Simmons D Kenealy T Scott DJ. Implementing the South Auckland diabetes plan: barriers and lessons. N Z Med J. (2000) 113: 364– 6. Available online at: https://www.proquest.com/docview/1138546217 11130372
  9. [13]Metcalf PA Scragg RR Schaaf D Dyall L Black PN Jackson RT. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey. N Z Med J. (2008) 121: 45– 56. 18278081
  10. [19]Goodyear-Smith F Ashton T. New Zealand health system: universalism struggles with persisting inequities. Lancet. (2019) 394: 432– 42. 10.1016/S0140-6736(19)31238-3 31379334 · DOI
  11. [20]Kenealy T Elley C Robinson E Bramley D Drury P Kerse N. An association between ethnicity and cardiovascular outcomes for people with Type 2 diabetes in New Zealand. Diabet Med. (2008) 25: 1302– 8. 10.1111/j.1464-5491.2008.02593.x 19046220 · DOI
  12. [21]Thomson M. Who had access to doctors before and after new universal capitated subsidies in New Zealand? Health Policy. (2019) 123: 756– 64. 10.1016/j.healthpol.2019.04.004 31213333 · DOI
  13. [22]Stormacq C Van den Broucke S Wosinski J. Does health literacy mediate the relationship between socioeconomic status and health disparities? Integrative review. Health Promot Int. (2019) 34: e1e17. 10.1093/heapro/day062 30107564 · DOI · Paper page
  14. [23]Schmidt-Busby J Wiles J Exeter D Kenealy T. Understandings of disease among Pacific peoples with diabetes and end-stage renal disease in New Zealand. Health Expect. (2019) 22: 1122– 31. 10.1111/hex.12946 31368649 PMC6803558 · DOI
  15. [24]Morera J Joubert M Morello R Rod A Lireux B Reznik Y. Sustained efficacy of insulin pump therapy in type 2 diabetes: 9-year follow-up in a cohort of 161 patients. Diabetes Care. (2016) 39: e74e75. 10.2337/dc16-0287 27208322 · DOI
  16. [25]Landau Z Raz I Wainstein J Bar-Dayan Y Cahn A. The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. (2017) 33: e2822. 10.1002/dmrr.2822 27189155 · DOI
  17. [28]McKergow E Parkin L Barson DJ Sharples KJ Wheeler BJ. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study. Acta Diabetol. (2017) 54: 63– 71. 10.1007/s00592-016-0912-7 27650535 · DOI
  18. [29]Sa'uLilo L Tautolo ES Egli V Smith M. Health literacy of Pacific mothers in New Zealand is associated with sociodemographic factors and non-communicable disease risk factors: surveys, focus group and interviews. J Pacific Res. (2018) 21: 67– 70. 10.26635/phd.2018.914 · DOI
  19. [30]Payne M Pooke F Chase JG Campbell J Holder-Pearson L Knopp J. The separation of insulin pump hardware and software - a novel and low-cost approach to insulin pump design. IFAC-PapersOnLine. (2021) 54: 502– 7. 10.1016/j.ifacol.2021.10.306 · DOI
  20. [31]Coppell KJ Drabble SJ Cochrane JA Stamm RA Sullivan TA. The cost of diabetes-related hospital care to the Southern District Health Board in 2016/17. N Z Med J. (2019) 132: 35– 45. 31647793
  21. [32]Graham R Masters-Awatere B. Experiences of Māori of Aotearoa New Zealand's public health system: a systematic review of two decades of published qualitative research. Aust N Z J Public Health. (2020) 44: 193– 200. 10.1111/1753-6405.12971 32311187 · DOI
  22. [33]Hennessy LD Lange MD Wiltshire EJ Jefferies C Wheeler BJ. Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes. Diabetic Medicine. (2020) 38: 14450. 10.1111/dme.14450 33131079 · DOI
  23. [34]Bauchner H. Rationing of health care in the United States. JAMA. (2019) 321: 751. 10.1001/jama.2019.1081 30758496 · DOI
  24. [35]Crowshoe L Dannenbaum D Green M Henderson R Hayward MN Toth E. Type 2 diabetes and indigenous peoples. Can J Diabetes. (2018) 42: S296306. 10.1016/j.jcjd.2017.10.022 29650108 · DOI
  25. [36]Maple-Brown LJ Graham S McKee J Wicklow B. Walking the path together: incorporating Indigenous knowledge in diabetes research. Lancet Diabet Endocrinol. (2020) 8: 559– 60. 10.1016/S2213-8587(20)30188-1 32559468 · DOI
  26. [37]Tatulashvili S Fagherazzi G Dow C Cohen R Fosse S Bihan H. Socioeconomic inequalities and type 2 diabetes complications: a systematic review. Diabet Metab. (2020) 46: 89– 99. 10.1016/j.diabet.2019.11.001 31759171 · DOI
  27. [38]Sharma S Walton M Manning S. Social determinants of health influencing the New Zealand COVID-19 response and recovery: a scoping review and causal loop diagram. Systems. (2021) 9: 52. 10.3390/systems9030052 · DOI
  28. [39]Curtis E Paine SJ Jiang Y Jones P Tomash I Healey O. Examining emergency department inequities in Aotearoa New Zealand: Findings from a national retrospective observational study examining Indigenous emergency care outcomes. Emerg Med Austr. (2021) 34: 16– 23. 10.1111/1742-6723.13876 34651443 PMC9293399 · DOI
  29. [40]Campbell J Holder-Pearson L Pretty C Benton C Knopp J Chase J. Development of a NIR light absorption reflectance pulse glucometer. IFAC-PapersOnLine. (2020) 53: 15970– 5. 10.1016/j.ifacol.2020.12.388 · DOI

Cited by

Sorted by citations

Authors
Holder-Pearson, L., & Chase, J. G.
Venue
Frontiers in Medicine
Publisher
Frontiers Media SA
Published
2022-05-10
Volume
9
ISSN
2296-858X
DOI
10.3389/fmed.2022.756223
PMC
PMC9127724
Cited by
32
References
1
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
Ministry of Business, Innovation and Employment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review